Myelofibrosis is bone marrow cancer that disturbs the formation of blood cells. It is a rare type of cancer in which the patient remains asymptomatic for some time. However, it can cause a severe type of anemia with weakness.
Fedratinib - Mechanism of Action, Indications, Dosage, and Adverse Drug Reactions
Fedratinib, an oral medication, treats adult patients with intermediate-2 or high-risk myelofibrosis (MF).
Post-essential Thrombocythemia Myelofibrosis - An Overview
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) is a rare hematological disorder arising from Essential Thrombocythemia.
Pediatric Immune Myelofibrosis: Navigating a Rare Condition
Pediatric immune myelofibrosis is a rare disorder characterized by the growth of fibrous tissue in the bone marrow, which causes hematologic abnormalities.
Primary Myelofibrosis - Causes, Symptoms, Diagnosis, and Treatment
Primary myelofibrosis is a condition of the blood system in which the bone marrow tissue is replaced by scar tissue. Read to know more.
